Cargando…
666. Microbial Cell-Free DNA Sequencing for Evaluation of Response to Antibiotic Therapy in Patients with Relapsed or Refractory Leukemia
BACKGROUND: In patients with bloodstream infection (BSI), true eradication of infection takes longer than blood culture clearance. Therefore, optimal treatment duration, especially in immunocompromised hosts, is unknown. A sensitive test of microbiological response to treatment could improve care by...
Autores principales: | Wolf, Joshua, Goggin, Kathryn, griffen, Amanda, Kohler, Christina, Allison, Kim J, Inaba, Yuki, Ahmed, Asim A, Hollemon, Desiree D, Brenner, Abigail, Maron, Gabriela, Sun, Yilun, Tang, Li, Gawad, Charles, Margolis, Ellie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776736/ http://dx.doi.org/10.1093/ofid/ofaa439.859 |
Ejemplares similares
-
1097. Microbial Cell Free DNA Sequencing for Prediction of Culture-Negative Infection Events in Children with Cancer
por: Goggin, Kathryn, et al.
Publicado: (2020) -
1756. Prediction of Bloodstream Infection Prior to Onset of Symptoms by Plasma Metagenomic Sequencing in Pediatric Patients With Relapsed or Refractory Malignancy (PREDSEQ)
por: Goggin, Kathryn, et al.
Publicado: (2018) -
Evaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory Cancer
por: Goggin, Kathryn P., et al.
Publicado: (2019) -
78. Non-Invasive Prediction of Invasive Fungal Infection by Plasma-Based Microbial Cell-Free DNA Next-Generation Sequencing (mcfDNA NGS) in Pediatric Patients with Relapsed or Refractory Leukemia
por: Wolf, Joshua, et al.
Publicado: (2021) -
Run 666, R1 + R2
por: Accomazzo, C, et al.
Publicado: (1976)